141 related articles for article (PubMed ID: 14654709)
1. Tumor marker workshops.
Rye PD; Nustad K; Stigbrand T
Tumour Biol; 2003; 24(4):165-71. PubMed ID: 14654709
[TBL] [Abstract][Full Text] [Related]
2. CA 125, CA 15.3, CA 27.29, CEA, beta-hCG and alpha-fetoprotein levels in cyst fluid of breast macrocysts.
Martínez L; Castilla JA; Blanco N; Perán F; Herruzo A
Int J Gynaecol Obstet; 1995 Feb; 48(2):187-92. PubMed ID: 7540567
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of serum carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), carbohydrate antigen 19-9 (CA19-9), carbohydrate antigen 15-3 (CA15-3), alpha-fetoprotein (AFP) and human chorionic gonadotropin (hCG) levels in determining the malignancy of solitary pulmonary nodules.
Bekci TT; Senol T; Maden E
J Int Med Res; 2009; 37(2):438-45. PubMed ID: 19383238
[TBL] [Abstract][Full Text] [Related]
4. An immunohistochemical study of keratin, carcinoembryonic antigen, human chorionic gonadotropin and alpha-fetoprotein in lung cancer.
Kimura N; Ghandur-Mnaymen L
Tohoku J Exp Med; 1985 Jan; 145(1):23-38. PubMed ID: 2580364
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of germ cell and trophoblastic neoplasms.
Niehans GA; Manivel JC; Copland GT; Scheithauer BW; Wick MR
Cancer; 1988 Sep; 62(6):1113-23. PubMed ID: 2457424
[TBL] [Abstract][Full Text] [Related]
6. The impact of local guidelines on the tumour marker requesting patterns of a General Surgery Department.
Schulenburg-Brand D; Kumar N; Zouwail S
Ann Clin Biochem; 2013 Sep; 50(Pt 5):438-42. PubMed ID: 23828945
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of circulating tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
[TBL] [Abstract][Full Text] [Related]
8. Patterns of seminoma tissue markers and deletions.
Yamamoto H; Rudén U; Ljungdahl-Ståhle E; Brehmer-Andersson E; Hirano K; Hisazumi H; Stigbrand T; Wahren B
Int J Cancer; 1987 Nov; 40(5):615-9. PubMed ID: 2445700
[TBL] [Abstract][Full Text] [Related]
9. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of cancer using microchip-based system for simultaneous quantitation of six tumor markers.
Ryabykh TP; Sokolova ZA; Paklin NB; Osipova TV
Dokl Biochem Biophys; 2011; 437():98-101. PubMed ID: 21590386
[No Abstract] [Full Text] [Related]
11. [Studies on the tumor markers in the germinal testicular tumors. Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG) and carcinoembryonic antigen (CEA) in germinal testicular tumors using an indirect immunoperoxidase method].
Miki T
Nihon Hinyokika Gakkai Zasshi; 1984 Mar; 75(3):503-22. PubMed ID: 6206269
[No Abstract] [Full Text] [Related]
12. Reflection on the discovery of carcinoembryonic antigen, prostate-specific antigen, and cancer antigens CA125 and CA19-9.
Diamandis EP; Bast RC; Gold P; Chu TM; Magnani JL
Clin Chem; 2013 Jan; 59(1):22-31. PubMed ID: 23204222
[No Abstract] [Full Text] [Related]
13. Human first trimester fetal ovaries express oncofetal antigens and steroid receptors.
Gould DA; Moscoso GJ; Young MP; Barton DP
J Soc Gynecol Investig; 2000; 7(2):131-8. PubMed ID: 10785614
[TBL] [Abstract][Full Text] [Related]
14. Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System.
Christenson RH; Cervelli DR; Sterner J; Bachmann LM; Rebuck H; Gray J; Kelley WE
Clin Biochem; 2011 Sep; 44(13):1128-1136. PubMed ID: 21704611
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
Purnell DM; Heatfield BM; Trump BF
Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
[TBL] [Abstract][Full Text] [Related]
16. Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review.
Laraib U; Sargazi S; Rahdar A; Khatami M; Pandey S
Int J Biol Macromol; 2022 Jan; 195():356-383. PubMed ID: 34920057
[TBL] [Abstract][Full Text] [Related]
17. Tumor markers in hemodialysis patients.
Arican A; Ozdemir N; Sezer S; Erten Y; Güz G; Turan M; Inanoglu I; Haberal M
Transplant Proc; 1999 Dec; 31(8):3367-8. PubMed ID: 10616509
[No Abstract] [Full Text] [Related]
18. Tumor markers in hydrocele fluids of patients with benign and malignant scrotal diseases.
Dorfinger K; Kratzik C; Madersbacher S; Dorfinger G; Berger P; Marberger M
J Urol; 1997 Sep; 158(3 Pt 1):851-5. PubMed ID: 9258097
[TBL] [Abstract][Full Text] [Related]
19. [Molecular microheterogeneity of tumor marker substances and its significance of biological recognition].
Kuwabara M; Iwakoshi N; Ariyoshi Y
Nihon Rinsho; 1996 Jun; 54(6):1580-6. PubMed ID: 8691612
[TBL] [Abstract][Full Text] [Related]
20. [Cellular localization of alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and carcinoembryonic antigen (CEA) in malignant germ cell tumors of the ovary using immunoperoxidase technique (author's transl)].
Obata N; Kodama S; Hando T; Takeuchi S
Nihon Sanka Fujinka Gakkai Zasshi; 1980 Jun; 32(6):757-66. PubMed ID: 6165791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]